LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Liquid Media Found Practical for Diarrheagenic Parasite

By LabMedica International staff writers
Posted on 12 Dec 2011
Print article
Image: The anaerobic intestinal protozoan Blastocystis hominis (Photo courtesy of K-State).
Image: The anaerobic intestinal protozoan Blastocystis hominis (Photo courtesy of K-State).
A common protozoan in the human intestinal tract that can cause the so-called blastocystosis characterized by diarrhea, can be grown in liquid culture media.

In vitro culture methods could be safe alternatives to identify Blastocystis hominis for both clinical diagnosis and field study purposes, as present methods are potentially toxic to laboratory personnel.

Scientists at Xi’an Jiaotong University (China) isolated eight samples of B. hominis from symptomatic patient fresh stool samples. More than five B. hominis cells were seen per high-power magnification field. To determine whether in vitro culture could be an environmentally safe alternative, the culture growth of B. hominis observed and compared in three commercially available liquid media: Roswell Park Memorial Institute (RPMI) 1640, 199 Medium, and Dulbecco's modified Eagle's medium (DMEM). The sensitivity and specificity of these culture methods to identify B. hominis were compared with those of existing methods used clinically.

The anaerobic culture of B. hominis in these media required a total inoculum sizes of no less than 105 cells; pH values ranging from 7.0 to 7.5; concentrations of calf or horse serum ranging from 10% to 30%; and basic antibiotics have to be added. Growth peaking times were at days 3, 6, and 9 at pH 7.5 or days 4 and 8 or 9 at pH 7.0 at 37 °C. No significant differences were noted in multiplication or generation times for the cultivation of B. hominis. In 56 of 398 positive cases, the short-term in vitro culture method achieved the best performance with regard to sensitivity and specificity of the five methods studied. All three culture media were from the Gibco (Carlsbad, CA, USA) range of culture media. B. hominis identification has depended on the discovery of vacuolar, granular, amoebic, or cystic forms in stool samples using wet mount smears, iodine staining, trichrome staining, or iron hematoxylin staining.

The authors concluded that the in vitro culture method had the advantage of environmental safety, convenience in preparation and storage, facility in morphologic discrimination, and outstanding performance in terms of sensitivity and specificity, and could be applied to identify B. hominis for clinical diagnosis except in emergency situations. Prevalence surveys in China suggest that about 6% of patients with diarrhea have blastocystosis. The study was published on November 11, 2011, in the International Journal of Infectious Diseases.

Related Links:

Xi’an Jiaotong University
Gibco


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more